Replies to post #251471 on Biotech Values

[DewDiligence]

PACB—Slow payment by customers would boost the Accounts receivable line, but it wouldn’t reduce revenue (unless some of the payments were deemed unrecoverable). There must be another explanation for the revenue flatlining.